Insurance coverage varies: Ozempic is often covered for diabetes, while Wegovy or Semaglutide for weight loss may have stricter approval criteria
Sale is limited to laboratory research applications
The ROIs chosen converged on key nodes in the appetitive and reward network, most consistently including the amygdala (5 studies), insula (6 studies), striatum (putamen: 5 studies
Your insurance company will review this request and decide whether to cover the medication
Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity